Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | DRL_RI |
Trade Name | |
Synonyms | DRL-rituximab |
Drug Descriptions |
DRL_RI is a potential biosimilar of rituximab, which may lead to complement and antibody-dependent cytotoxicity towards CD20-positive tumor cells (PMID: 31809224). |
DrugClasses | CD20 Antibody 24 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
DRL_RI | DRL_RI | 0 | 1 |